Europe
-
One fifth of COVID cases likely asymptomatic
About a fifth of people infected with COVID-19 are asymptomatic – although the proportion may be greater among health workers, according to new studies. Read more
-
What does COVID-19 mean for type 1 diabetes?
The pandemic has led to new patients with type 1 diabetes presenting with increasingly severe symptoms, a European conference will hear today. Read more
-
Combination treatment could attack aggressive prostate cancers
An experimental cancer drug combined with targeted hormone treatment could treat an aggressive group of prostate cancers, a European conference has heard. Read more
-
Access to cancer medicines and trials vary across Europe
Access to cancer medicines varies widely across Europe both for new drugs in development and for currently approved drugs, a conference has heard. Read more
-
Breast cancer patients should receive brain scans
Women with breast cancer should receive brain scans to ensure metastatic disease is identified while it is asymptomatic, according to a new analysis. Read more
-
Molecule might restore brain and spinal cord function
A molecule has been created that might repair and restore brain and spinal cord function in mice with neurological disorders, it has been announced. Read more
-
Europe struggles with vaccine doubts
Europe may struggle to get the public to use any approved COVID-19 vaccine, according to an analysis published yesterday. Read more
-
Form of natural hormone might prevent sarcopenia
A possible new treatment has been identified to restore the common age-related loss of muscle mass and strength. Read more
-
Genotype testing improves paediatric asthma care
Personalising treatments according to genetic differences could help some children with asthma, a medical congress will hear today (8 September 2020). Read more
-
Vaccines may not be silver bullet
Experts have warned against excessive optimism over COVID-19 vaccines – with one senior scientist warning they would not be a “silver bullet.” Read more